S. 1553 · 119th Congress · Commerce
PREVAIL Act
- IntroducedMay 1, 2025 Done
- CommitteeReferred to Judiciary Current stage
- Senate floorNot yet Not reached yet
- House floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
What it does
This bill addresses various issues relating to the U.S. Patent and Trademark Office (USPTO), including by imposing additional requirements on administrative patent validity challenges (proceedings to review and potentially cancel issued patents) at the USPTO.
The bill modifies provisions relating to inter partes reviews (IPRs) and other administrative patent validity proceedings, including by
• prohibiting an administrative patent judge who participated in deciding whether to institute an IPR (i.e., whether to allow the IPR to proceed based on the initial petition) from also participating in deciding the final outcome of the same IPR;
• prohibiting a person (individual or entity) from petitioning for an IPR against a patent unless the person meets certain standing requirements (currently, any person may petition for an IPR);
• prohibiting a person who has challenged a patent's validity in an IPR from raising the same challenges against the patent in other proceedings (e.g., district court) if the IPR has been instituted; and
• raising the burden that the petitioner in an IPR must meet to invalidate a previously issued patent claim.
The bill also makes institutions of higher education (IHEs) and nonprofit entities that hold patents on behalf of IHEs eligible for reduced patent-related fees, including filing fees. (Currently, employees of IHEs are eligible for reduced fees but not the IHEs themselves.)
The bill also makes fees collected by the USPTO available for the USPTO's use without further appropriations from Congress.
Congressional Research Service · summary of “Introduced in Senate” version · May 1, 2025
Who lobbies on it
14 organizations, more than 98% of Senate bills · 88 filings, incl. 6 naming only H.R. 3160 · Q2 2025–Q3 2026One square per quarter since introduction, oldest left. Filled = named S. 1553 or H.R. 3160 that quarter.
-
Pharmaceutical Research and Manufacturers of America
6 of 6 quarters
“…S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act…”
$26.6M lobbying spend in 2026 to date, all issuesQ3 2026 filing · names both
-
Microsoft Corporation
6 of 6 quarters
“Software copyright and related policy issues. Software patents and related policy issues. S. 1553, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act. S. 1546, Patent Eligibility Restoration Act. S. 1367, NO FAKES Act. S. 4098, AI Ready Data Act.”
$7.5M lobbying spend in 2026 to date, all issuesQ3 2026 filing
-
Novartis
6 of 6 quarters
“…H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) Restrictions on Intellectual Property Rights PTAB reform Patent fee policy issues Section 101 reform”
$6.2M lobbying spend in 2026 to date, all issuesQ3 2026 filing · names H.R. 3160 only
11 more organizations, every filingPROUpgrade
Organizations that named S. 1553 or its companion H.R. 3160 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Reports naming only H.R. 3160 are included and tagged. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Members sponsoring the companion, H.R. 3160, are counted on that bill’s page, not here. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.
Actions
2 actions · newest first- May 1, 2025Read twice and referred to the Committee on the Judiciary.
- May 1, 2025Introduced in Senate